Company Lookup
عربي
Download Demo
 

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals (PHARMACARE)

Overview

PHARMACARE
Overview
 

Dar Al-Shifa"a for the Manufacturing of Pharmaceuticals (PHARMACARE) was incorporated in 1986. Its activities include manufacturing, selling, distribution, export and import of medicines, cosmetics, chemicals and veterinary products. The company had been engaged—during 1999 and 2000- in equity finance through cooperation with Michael Wirts and his family– owners of Grunenthal GMBH; a reputable German Company involved in pharmaceutical manufacturing– to finalize its new factory. The cooperation with GMBH strengthened the technology support, training and knowledge transfer  and granted the right for Dar Al-Shifa"a  in manufacturing and distributing some of Grunenthal products which will ensure continuous growth in Dar Al-Shifa"a sales and enhance its ability to overcome the competition challenges.  At the end of 2011, Wirts family reduced their stake in Dar Al-Shifa"a. Therefore, the company"s management decided to include Bank of Palestine and Reach for Investment & Development as shareholders. The German partner holds now a stake of 23.92% of Dar Al-Shifa"a s shares.

 
Year Total revenues Total expenses Net income (Loss) Dividends Capital Subscribed Capital Market Cap
2011 19,464,154 3,626,456 2,028,890 - 8,462,623 8,462,623 -
2012 15,364,226 4,102,762 2,027,972 - 8,462,623 8,462,623 -
2013 15,906,232 3,442,580 2,117,685 8% Cash 8,462,623 8,462,623 33,427,361
2014 15,634,114 3,337,508 1,746,987 8% Cash 10,000,000 8,462,623 31,650,210
2015 16,361,404 9,389,877 1,849,164 8% cash 10,000,000 8,462,623 31,734,836
2016 17,706,585 10,256,170 3,414,672 - 10,000,000 8,462,623 30,550,069
 
  • Jerusalem Pharmaceutical Company (JPH)
  • Birzeit Pharmaceutical Company (BPC)
 
 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013